Viatris lowers 2022 guidance to reflect currency impact [Seeking Alpha]
Viatris Inc. (VTRS)
Company Research
Source: Seeking Alpha
Viatris lowers 2022 guidance to reflect currency impactAug. 08, 2022 7:49 AM ETViatris Inc. (VTRS)By:Dulan LokuwithanaSA News EditorZerbor/iStock via Getty ImagesThe shares of the generic drugmaker, Viatris (NASDAQ:traded ~4% higheraccount for the rising U.S. dollar.Revenue for the quarter dropped ~10% YoY on a reported basis to $4.1B, and the sales decline stood at only ~3% on an operational basis to exceed forecasts amid outperformance in segments such as Developed , Emerging , andChina, the company said.Net sales from developed and emerging markets slipped ~6% YoY and ~25% YoY to $2.5B and $650.9M, respectively, while sales in China remained steady at $548.3M compared to 2Q 2021.Despite an ~8% YoY decline, Vatris (As GAAP gross margin improved to 41.4% from ~29.0% in 2Q 2021, Viatris (Citing ~$800M negative impact of foreign exchange rates, the management has lowered the 2022 revenue guidance to $16.2B-$16.7B from the prior outlook of $17B-$17.5B.However, expecting to absorb the im
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and Healthcare [Yahoo! Finance]Yahoo! Finance
- Viatris to Report First Quarter 2024 Financial Results on May 9, 2024PR Newswire
- Viatris Appoints Corinne Le Goff as Chief Commercial Officer [Yahoo! Finance]Yahoo! Finance
- Viatris Appoints Corinne Le Goff as Chief Commercial OfficerPR Newswire
- Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 2/28/24 - Miss
VTRS
Sec Filings
- 4/4/24 - Form 4
- 3/15/24 - Form 4
- 3/11/24 - Form 144
- VTRS's page on the SEC website